Megan Settle
Impact in
- Clinical Biochemistry top 2%
- Paraoxonase enzyme and polymorphisms
- Immunology top 5%
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Atherosclerosis and Cardiovascular Diseases
Papers in
-
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms 3
- Atherosclerosis and Cardiovascular Diseases 2
- Surgery 4
- Cholesterol and Lipid Metabolism 4
- Co-authors
- Jonathan D. Smith (9 shared papers)Lemin Zheng (4 shared papers)Stanley L. Hazen (4 shared papers)Michael Kinter (4 shared papers)Harry Ischiropoulos (2 shared papers)Leonor Thomson (2 shared papers)Marlene Goormastic (2 shared papers)Xiaoming Fu (2 shared papers)
- Journals
- Journal of Lipid Research (2 papers)Arteriosclerosis Thrombosis and Vascular Biology (2 papers)Journal of Biological Chemistry (2 papers)Journal of Clinical Investigation (2 papers)Mammalian Genome (1 paper)
- Partner nations
- United StatesIndiaFrance
In The Last Decade
Megan Settle
10 papers receiving 1.7k citations
Megan Settle's Hit Papers
Peers
Comparison fields: 5 of 85
- Clinical Biochemistry 238
- Immunology 574
- Endocrinology, Diabetes and Metabolism 370
- Biochemistry 118
- Surgery 562
Countries citing papers authored by Megan Settle
This map shows the geographic impact of Megan Settle's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan Settle with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan Settle more than expected).
Fields of papers citing papers by Megan Settle
This network shows the impact of papers produced by Megan Settle. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan Settle. The network helps show where Megan Settle may publish in the future.
Co-authors
The 25 scholars most cited alongside Megan Settle, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease Hit paper breakdown → | 2004 | 589 |
| 2 | Apolipoprotein A-I is a selective target for myeloperoxidase-catalyzed oxidation and functional impairment in subjects with cardiovascular disease Hit paper breakdown → | 2004 | 577 |
| 3 | 2004 | 179 | |
| 4 | 2004 | 112 | |
| 5 | 2004 | 75 | |
| 6 | 2014 | 71 | |
| 7 | 2005 | 67 | |
| 8 | 2005 | 43 | |
| 9 | 2005 | 43 | |
| 10 | 2006 | 16 |
About Megan Settle
Megan Settle is a scholar working on Immunology, Surgery, Molecular Biology, Physiology and Oncology, having authored 10 papers that have together received 1.8k indexed citations. Recurring topics across this work include Peroxisome Proliferator-Activated Receptors (4 papers), Cholesterol and Lipid Metabolism (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Neutrophil, Myeloperoxidase and Oxidative Mechanisms (3 papers), Advanced Glycation End Products research (2 papers), Atherosclerosis and Cardiovascular Diseases (2 papers), Drug Transport and Resistance Mechanisms (2 papers) and Erythrocyte Function and Pathophysiology (1 paper). The work is most often cited by research in Clinical Biochemistry (238 citations), Immunology (574 citations), Endocrinology, Diabetes and Metabolism (370 citations), Biochemistry (118 citations) and Surgery (562 citations). Megan Settle has collaborated with scholars based in United States, India and France. Frequent co-authors include Jonathan D. Smith, Lemin Zheng, Stanley L. Hazen, Michael Kinter, Harry Ischiropoulos, Leonor Thomson, Marlene Goormastic, Xiaoming Fu, Mingjiang Sun and Paul L. Fox. Their work appears in journals such as Journal of Lipid Research, Arteriosclerosis Thrombosis and Vascular Biology, Journal of Biological Chemistry, Journal of Clinical Investigation and Mammalian Genome.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.